JANE EREMUS-FOSTER: Open Payments
NPI 1760853188 · MANAHAWKIN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$863 in 49 payments from 17 companies in 2025. Trend: 2023 $285 · 2024 $482 · 2025 $863
Food & beverage: $863
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $172 |
| Novo Nordisk Inc | 10 | $146 |
| ABBVIE INC. | 4 | $72 |
| Lilly USA, LLC | 4 | $69 |
| Lundbeck LLC | 4 | $62 |
| Axsome Therapeutics, Inc. | 3 | $53 |
| PFIZER INC. | 3 | $52 |
| Astellas Pharma US Inc | 3 | $48 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
| Hologic Sales and Service, LLC | 2 | $34 |
Products named: REXULTI, VRAYLAR, FARXIGA, Rybelsus, Auvelity, PREVNAR 20, BREZTRI, MOUNJARO.
Industry payments across NJ — which companies pay providers there.
